Sunday, August 2, 2015

FDA warns consumers against OTC chelation products

Parents of children with autism or relatives of people with Alzheimer's or Parkinson's sometimes turn to so-called chelation products purchased on the internet and elsewhere to treat these serious health conditions. Chelation products are intended to remove heavy metal from the body, but Thursday the Food and Drug Administration warned consumers that there are no such products approved for over-the-counter sale.

FDA warns consumers against OTC chelation products

0 comments

Parents of children with autism or relatives of people with Alzheimer’s or Parkinson’s sometimes turn to so-called chelation products purchased on the internet and elsewhere to treat these serious health conditions.

Chelation products are intended to remove heavy metal from the body, but Thursday the Food and Drug Administration warned consumers that there are no such products approved for over-the-counter sale.

Moreover, the federal agency warned that there are “serious safety issues associated with chelation products, which can alter the levels of certain substances in the blood.  Even when used under medical supervision, these products can cause serious harm, including dehydration, kidney failure, and death.”

The FDA said it has seen a rise in “chelation therapy” products being sold on the Internet. Often sold as dietary supplements, these chemicals are really unapproved drugs that claim to treat diseases. The products come in various forms ranging from sprays and suppositories to pills, drops and “clay baths.”

On Tuesday October 12, the FDA issued warning letters to eight companies, telling them to cease the improper sale of these products or face legal action.

The FDA issued such letters to the following companies:

  • Artery Health Institute, LLC of New York, New York
  • Cardio Renew, Inc of Apple Valley, Minnesota
  • Dr. Rhonda Henry of Dayton, Nevada
  • Evenbetternow, LLC of Oro Valley, Arizona.
  • Hormonal Health, LLC and World Health Products, LLC of San Bernardino, California
  • Longevity Plus of Payson, Arizona
  • Maxam Nutraceutics/Maxam Laboratories of Hood River, Oregon
  • World Health Products, LLC of Draper, Utah

“These products are dangerously misleading because they are targeted to patients with serious conditions and limited treatment options,” said Deborah Autor, director of the FDA’s office of compliance in the Center for Drug Evaluation and Research. “The FDA must take a firm stand against companies who prey on the vulnerability of patients seeking hope and relief.”

To check out more Check Up items go to www.philly.com/checkup.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter